Results 21 to 30 of about 1,148,410 (327)

Pharmaceutical Innovations: Superior Position of the USA and Weaknesses of German Research

open access: yesWirtschaftsdienst, 2021
The innovative strength of research performance is often measured in terms of inputs such as research funds or outputs such as patent applications. We present a novel indicator of pharmaceutical innovativeness that focuses on global medical breakthroughs
Andreas Eckert, Wolfgang Maennig
doaj   +1 more source

Evergreening of pharmaceutical patents: A blithe disregard for the rationale of the patent system

open access: yesJournal of Generic Medicines The Business Journal for the Generic Medicines Sector, 2019
Evergreening of pharmaceutical patents has emerged as a serious challenge for access to affordable drugs as it aims to delay the generic competition by extending the length of the exclusivity period beyond the legitimate patent term without any ...
M. Z. Abbas
semanticscholar   +1 more source

TRIPS implementation and secondary pharmaceutical patenting in Brazil and India [PDF]

open access: yes, 2015
This article compares national approaches toward secondary pharmaceutical patents. Because secondary patents can extend periods of exclusivity and delay generic competition, they can raise prices and reduce access to medicines. Little is known about what
Sampat, Bhaven N., Shadlen, Kenneth C.
core   +2 more sources

A Review on the Main Phytoconstituents, Traditional Uses, Inventions, and Patent Literature of Gum Arabic Emphasizing Acacia seyal

open access: yesMolecules, 2022
Acacia seyal is an important source of gum Arabic. The availability, traditional, medicinal, pharmaceutical, nutritional, and cosmetic applications of gum acacia have pronounced its high economic value and attracted global attention.
Mohamed A. Ashour   +5 more
doaj   +1 more source

The Contrasting Perceptions and the Cause Regarding Patenting Technologies Between Academic Medical Researchers and Pharmaceutical Companies Based in Japan

open access: yesJournal of Multidisciplinary Healthcare, 2021
Kazunari Sugimitsu,1,2 Yoshinobu Manome2 1Graduate School of Innovation Management, Kanazawa Institute of Technology, Tokyo, Japan; 2Core Research Facilities, Jikei University School of Medicine, Tokyo, JapanCorrespondence: Kazunari SugimitsuGraduate ...
Sugimitsu K, Manome Y
doaj  

Bridging the gap in patent assessment: The Index of Internal Effort framework for pharma innovations [PDF]

open access: yesJournal of Pharmacy & Pharmacognosy Research
Context: The process of assessing patents is complex, and there is a gap in the literature on patent assessment at the time of filing. Aims: To assess patent complexity and the human effort involved in research, we test the effectiveness of the Index ...
Alisson A. de Oliveira   +2 more
doaj   +1 more source

Implications of the pharmaceutical industry on the economies of developing countries [PDF]

open access: yesمجلة الاجتهاد للدراسات القانونية والاقتصادية, 2021
The pharmaceutical industry is a strategic industry that is critical to health security and, to a greater extent, national security, enabling developed countries to take indirect control through pharmaceutical patents on developing countries, thanks to
مالكي محمد   +1 more
doaj   +1 more source

Drug patenting in India: looking back andlooking forward [PDF]

open access: yes, 2015
It has now been 20 years since the TRIPS Agreement, which established minimum standards for intellectual property (IP) regulation, came into force. Its implementation in India has been controversial, and in particular Section 3(d), a provision designed ...
Sampat, Bhaven N., Shadlen, Kenneth C.
core   +1 more source

Pharmaceutical patents and the right to health – Portugal and Brazil (Vol.13, N.1)

open access: yesJanus.net, 2022
The defence of the patent system's legitimacy, namely in the pharmaceutical field, is consolidated, although it is not exempt from criticism. Historically, when the patent law, a legal monopoly right, is confronted with the right of access to
Ruben Bahamonde Delgado
doaj   +1 more source

In Defense of Secondary Pharmaceutical Patents: A Response to the UN's Guidelines for Pharmaceutical Patent Examination

open access: yes, 2017
In 2015 the United Nations Development Programme issued a document entitled Guidelines for Pharmaceutical Patent Examination: Examining Pharmaceutical Patents from a Public Health Perspective (the “Guidelines”).
Christopher M. Holman
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy